Literature DB >> 19018128

Warfarin-induced skin necrosis in a patient with heparin-induced thrombocytopenia: two diseases or one?

Omar I Abdel-Wahab1, Rachel P Rosovsky, James A Warth.   

Abstract

A 64-year-old woman with colon carcinoma presented with subsegmental pulmonary emboli. Platelet count on presentation was 598 x10(9)/l. The patient was anticoagulated with intravenous heparin. By hospital day 3, heparin was replaced with enoxaparin and warfarin. On hospital day 6, the patient developed a 20 x 15 cm area of necrotic skin on her left hip and a 1 x 3 cm area of necrosis on her right hip. By that time, her platelet count had fallen to 433 x 10(9)/l. Three days later (hospital day 9), anticoagulation was switched from the combination of enoxaparin and warfarin to argatroban. Her platelet count reached a nadir of 82 x 10(9)/l by the 12th hospital day. The areas of skin necrosis had never been sites of heparin injection. Heparin/platelet factor 4 antibody, sent on hospital day 9, returned positive and (14)C-serotonin release assay was also positive. This case illustrates that processes underlying heparin-induced thrombocytopenia (HIT) may also underlie warfarin-induced skin necrosis. Skin necrosis may be the earliest manifestation of HIT and need not be accompanied by thrombocytopenia. This patient's course illustrates that HIT should be considered in all patients presenting with skin necrosis while receiving anticoagulation with heparin or a combination of heparin and warfarin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018128     DOI: 10.1159/000174756

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Delayed warfarin induced skin necrosis in a patient with poor warfarin metabolizing activity due to interrupted warfarin therapy.

Authors:  Tejasvita Gaikwad; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

2.  Skin Necrosis Induced by Coumarin Congeners.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2017-08-01

3.  Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation.

Authors:  Mariya Apostolova; Baoying Weng; Harry H Pote; Harold Ashcraft; Curtis Goldblatt; Paul V Woolley
Journal:  Hematol Rep       Date:  2012-11-19

4.  Heparin-based hydrogel scaffolding alters the transcriptomic profile and increases the chemoresistance of MDA-MB-231 triple-negative breast cancer cells.

Authors:  Nidhi Menon; Ha X Dang; Udaya Sree Datla; Maryam Moarefian; Christopher B Lawrence; Christopher A Maher; Caroline N Jones
Journal:  Biomater Sci       Date:  2020-02-24       Impact factor: 6.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.